(Q41483401)

1 October 2017

1 reference

title

Interleukin-2 fusion protein: an investigational therapy for interleukin-2 receptor expressing malignancies (English)

1 reference

1 October 2017

J Nichols

1

1 reference

1 October 2017

F Foss

2

1 reference

1 October 2017

T M Kuzel

3

1 reference

1 October 2017

C F LeMaistre

4

1 reference

1 October 2017

L Platanias

5

1 reference

1 October 2017

M J Ratain

6

1 reference

1 October 2017

A Rook

7

1 reference

1 October 2017

M Saleh

8

1 reference

1 October 2017

G Schwartz

9

1 reference

1 October 2017

publication date

1 January 1997

1 reference

European Journal of Cancer

1 October 2017

published in

1 reference

1 October 2017

volume

33 Suppl 1

1 reference

1 October 2017

page(s)

S34-6

1 reference

Impact of interleukin-2-receptor-targeted cytotoxins on a unique model of murine interleukin-2-receptor-expressing malignancy

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

Cloning of the gamma chain of the human IL-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

Intracellular pathway of interleukin 2 following receptor-mediated endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

Expression of interleukin 2 receptors on activated human B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

Cutaneous lymphomas other than mycosis fungoides: follow-up study of 52 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

Cutaneous T-cell lymphoma: clinicopathological relationships, therapy and survival in ninety-two patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

Therapeutic alternatives in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900327-9

7 January 2021

10.1016/S0959-8049(96)00327-9

Identifiers

DOI

1 reference

1 October 2017

1 reference